Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,527,220
-$100,653,733 QoQ
Shares Held
10,043
-97.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,775
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Capital Management Group, Inc. holds $673,709,624 across 9 Drug Manufacturers - General names. ABBV ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
980,465 | $249,008,696 | |
| 2 | LLY |
ELI LILLY & Co
|
141,416 | $169,618,607 | |
| 3 | AZN |
Astrazeneca PLC
|
608,068 | $115,301,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
652,471 | $83,842,523 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
395,783 | $50,003,224 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
10,043 | $2,527,220 | |
| 7 | NVS |
Novartis AG
|
14,258 | $2,234,513 | |
| 8 | AMGN |
Amgen Inc
|
1,626 | $588,807 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,527,220 | 10,043 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $103,180,953 | 474,417 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $137,732,172 | 602,793 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $161,010,832 | 695,391 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $112,278,382 | 604,883 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $119,786,774 | 571,720 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $693,385 | 3,902 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $736,402 | 3,729 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,401,318 | 8,170 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $893,564 | 4,907 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $859,153 | 5,544 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,623,114 | 10,889 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,440,533 | 10,692 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,835,464 | 11,517 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $47,166,040 | 291,851 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $37,792,730 | 281,594 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $41,459,952 | 270,697 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,549,600 | 379,678 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $50,089,334 | 369,936 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $39,289,597 | 364,231 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $27,475,374 | 243,922 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,805,758 | 16,686 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,086,853 | 19,476 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,076,496 | 23,707 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,318,422 | 23,614 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,712,522 | 22,477 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||